^
Association details:
Biomarker:CENPI overexpression
Cancer:Glioma
Drug:Zejula (niraparib) (PARP inhibitor)
Direction:Resistant
Evidence:
Evidence Level:
Resistant: D – Preclinical
Title:

Loss of CENP-I Impairs Homologous Recombination and Sensitizes Cells to PARP1 Inhibition

Published date:
06/26/2021
Excerpt:
...cellular survival after ionizing radiation and Niraparib, a PARP1 small molecule inhibitor, exposures...Importantly, CENP-I expression is elevated in glioma tissue as compared to normal brain tissue. This elevated expression also correlates with poor overall patient survival.
DOI:
10.3390/cancers13133202